APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Famciclovir

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Famciclovir Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173990680320 December 2025191 pages

Choose your research edition.

Industry ResearchFamciclovir Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Famciclovir Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Famciclovir Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Famciclovir Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Famciclovir Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Famciclovir market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Famciclovir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Famciclovir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Famciclovir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Famciclovir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Famciclovir include Teva, Shandong Luoxin Pharmaceutical Group, Novartis, Mylan, Hainan choitec Pharmaceuticals, Chengdu Diao Pharmaceutical Group, Beijing Jialin Pharmaceutical, Macleods Pharmaceuticals and HISUN, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Famciclovir market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Famciclovir and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Famciclovir sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Famciclovir market size, projected growth trends, production technologies, key applications, and end-use industries.

Famciclovir Segment by Company

Teva

Shandong Luoxin Pharmaceutical Group

Novartis

Mylan

Hainan choitec Pharmaceuticals

Chengdu Diao Pharmaceutical Group

Beijing Jialin Pharmaceutical

Macleods Pharmaceuticals

HISUN

Hikma

HETERO

Cipla

Aurobindo Pharma

Apotex

Famciclovir Segment by Type

125 mg Tablets

250 mg Tablets

500 mg Tablets

Famciclovir Segment by Application

Cold Sores

Shingles

Genital Herpes

Famciclovir Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Famciclovir market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Famciclovir and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Famciclovir.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Famciclovir market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Famciclovir manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Famciclovir in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Famciclovir in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Famciclovir Industry Trends Table 2. Famciclovir Industry Drivers Table 3. Famciclovir Industry Opportunities and Challenges Table 4. Famciclovir Industry Restraints Table 5. Global Famciclovir Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Famciclovir Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Famciclovir Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Famciclovir Sales Market Share by Manufacturers Table 9. Global Famciclovir Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Famciclovir Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Famciclovir Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Famciclovir Manufacturers, Product Type & Application Table 13. Global Famciclovir Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Famciclovir by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 125 mg Tablets Table 17. Major Manufacturers of 250 mg Tablets Table 18. Major Manufacturers of 500 mg Tablets Table 19. Global Famciclovir Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 20. Global Famciclovir Sales by Type (2021-2026) & (W Units) Table 21. Global Famciclovir Sales by Type (2027-2032) & (W Units) Table 22. Global Famciclovir Sales Market Share by Type (2021-2026) Table 23. Global Famciclovir Sales Market Share by Type (2027-2032) Table 24. Global Famciclovir Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 25. Global Famciclovir Revenue by Type (2021-2026) & (W Units) Table 26. Global Famciclovir Revenue by Type (2027-2032) & (W Units) Table 27. Global Famciclovir Revenue Market Share by Type (2021-2026) Table 28. Global Famciclovir Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Cold Sores Table 30. Major Manufacturers of Shingles Table 31. Major Manufacturers of Genital Herpes Table 32. Global Famciclovir Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 33. Global Famciclovir Sales by Application (2021-2026) & (W Units) Table 34. Global Famciclovir Sales by Application (2027-2032) & (W Units) Table 35. Global Famciclovir Sales Market Share by Application (2021-2026) Table 36. Global Famciclovir Sales Market Share by Application (2027-2032) Table 37. Global Famciclovir Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 38. Global Famciclovir Revenue by Application (2021-2026) & (W Units) Table 39. Global Famciclovir Revenue by Application (2027-2032) & (W Units) Table 40. Global Famciclovir Revenue Market Share by Application (2021-2026) Table 41. Global Famciclovir Revenue Market Share by Application (2027-2032) Table 42. Global Famciclovir Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 43. Global Famciclovir Sales by Region (2021-2026) & (W Units) Table 44. Global Famciclovir Sales Market Share by Region (2021-2026) Table 45. Global Famciclovir Sales Forecasted by Region (2027-2032) & (W Units) Table 46. Global Famciclovir Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Famciclovir Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 48. North America Famciclovir Sales by Country (2021-2026) & (W Units) Table 49. North America Famciclovir Sales by Country (2027-2032) & (W Units) Table 50. Europe Famciclovir Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 51. Europe Famciclovir Sales by Country (2021-2026) & (W Units) Table 52. Europe Famciclovir Sales by Country (2027-2032) & (W Units) Table 53. Asia Pacific Famciclovir Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 54. Asia Pacific Famciclovir Sales by Country (2021-2026) & (W Units) Table 55. Asia Pacific Famciclovir Sales by Country (2027-2032) & (W Units) Table 56. South America, Middle East and Africa Famciclovir Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 57. South America, Middle East and Africa Famciclovir Sales by Country (2021-2026) & (W Units) Table 58. South America, Middle East and Africa Famciclovir Sales by Country (2027-2032) & (W Units) Table 59. Global Famciclovir Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Famciclovir Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Famciclovir Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Famciclovir Revenue Market Share by Region (2021-2026) Table 63. Global Famciclovir Revenue Market Share by Region (2027-2032) Table 64. Teva Company Information Table 65. Teva Business Overview Table 66. Teva Famciclovir Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Teva Famciclovir Product Portfolio Table 68. Teva Recent Development Table 69. Shandong Luoxin Pharmaceutical Group Company Information Table 70. Shandong Luoxin Pharmaceutical Group Business Overview Table 71. Shandong Luoxin Pharmaceutical Group Famciclovir Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Shandong Luoxin Pharmaceutical Group Famciclovir Product Portfolio Table 73. Shandong Luoxin Pharmaceutical Group Recent Development Table 74. Novartis Company Information Table 75. Novartis Business Overview Table 76. Novartis Famciclovir Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Novartis Famciclovir Product Portfolio Table 78. Novartis Recent Development Table 79. Mylan Company Information Table 80. Mylan Business Overview Table 81. Mylan Famciclovir Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Mylan Famciclovir Product Portfolio Table 83. Mylan Recent Development Table 84. Hainan choitec Pharmaceuticals Company Information Table 85. Hainan choitec Pharmaceuticals Business Overview Table 86. Hainan choitec Pharmaceuticals Famciclovir Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Hainan choitec Pharmaceuticals Famciclovir Product Portfolio Table 88. Hainan choitec Pharmaceuticals Recent Development Table 89. Chengdu Diao Pharmaceutical Group Company Information Table 90. Chengdu Diao Pharmaceutical Group Business Overview Table 91. Chengdu Diao Pharmaceutical Group Famciclovir Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Chengdu Diao Pharmaceutical Group Famciclovir Product Portfolio Table 93. Chengdu Diao Pharmaceutical Group Recent Development Table 94. Beijing Jialin Pharmaceutical Company Information Table 95. Beijing Jialin Pharmaceutical Business Overview Table 96. Beijing Jialin Pharmaceutical Famciclovir Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Beijing Jialin Pharmaceutical Famciclovir Product Portfolio Table 98. Beijing Jialin Pharmaceutical Recent Development Table 99. Macleods Pharmaceuticals Company Information Table 100. Macleods Pharmaceuticals Business Overview Table 101. Macleods Pharmaceuticals Famciclovir Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Macleods Pharmaceuticals Famciclovir Product Portfolio Table 103. Macleods Pharmaceuticals Recent Development Table 104. HISUN Company Information Table 105. HISUN Business Overview Table 106. HISUN Famciclovir Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. HISUN Famciclovir Product Portfolio Table 108. HISUN Recent Development Table 109. Hikma Company Information Table 110. Hikma Business Overview Table 111. Hikma Famciclovir Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Hikma Famciclovir Product Portfolio Table 113. Hikma Recent Development Table 114. HETERO Company Information Table 115. HETERO Business Overview Table 116. HETERO Famciclovir Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. HETERO Famciclovir Product Portfolio Table 118. HETERO Recent Development Table 119. Cipla Company Information Table 120. Cipla Business Overview Table 121. Cipla Famciclovir Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Cipla Famciclovir Product Portfolio Table 123. Cipla Recent Development Table 124. Aurobindo Pharma Company Information Table 125. Aurobindo Pharma Business Overview Table 126. Aurobindo Pharma Famciclovir Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Aurobindo Pharma Famciclovir Product Portfolio Table 128. Aurobindo Pharma Recent Development Table 129. Apotex Company Information Table 130. Apotex Business Overview Table 131. Apotex Famciclovir Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Apotex Famciclovir Product Portfolio Table 133. Apotex Recent Development Table 134. Key Raw Materials Table 135. Raw Materials Key Suppliers Table 136. Famciclovir Distributors List Table 137. Famciclovir Customers List Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources Table 141. Primary Sources List of Figures Figure 1. Famciclovir Product Image Figure 2. Global Famciclovir Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Famciclovir Market Size (2021-2032) & (US$ Million) Figure 4. Global Famciclovir Sales (2021-2032) & (W Units) Figure 5. Global Famciclovir Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Famciclovir Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 125 mg Tablets Image Figure 9. 250 mg Tablets Image Figure 10. 500 mg Tablets Image Figure 11. Global Famciclovir Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 12. Global Famciclovir Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Famciclovir Sales Market Share by Type (2021-2032) Figure 14. Global Famciclovir Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 15. Global Famciclovir Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Famciclovir Revenue Market Share by Type (2021-2032) Figure 17. Cold Sores Image Figure 18. Shingles Image Figure 19. Genital Herpes Image Figure 20. Global Famciclovir Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 21. Global Famciclovir Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Famciclovir Sales Market Share by Application (2021-2032) Figure 23. Global Famciclovir Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 24. Global Famciclovir Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Famciclovir Revenue Market Share by Application (2021-2032) Figure 26. North America Famciclovir Sales and Growth Rate (2021-2032) & (W Units) Figure 27. North America Famciclovir Sales Market Share by Country (2021-2032) Figure 28. U.S. Famciclovir Sales and Growth Rate (2021-2032) & (W Units) Figure 29. Canada Famciclovir Sales and Growth Rate (2021-2032) & (W Units) Figure 30. Mexico Famciclovir Sales and Growth Rate (2021-2032) & (W Units) Figure 31. Europe Famciclovir Sales and Growth Rate (2021-2032) & (W Units) Figure 32. Europe Famciclovir Sales Market Share by Country (2021-2032) Figure 33. Germany Famciclovir Sales and Growth Rate (2021-2032) & (W Units) Figure 34. France Famciclovir Sales and Growth Rate (2021-2032) & (W Units) Figure 35. U.K. Famciclovir Sales and Growth Rate (2021-2032) & (W Units) Figure 36. Italy Famciclovir Sales and Growth Rate (2021-2032) & (W Units) Figure 37. Netherlands Famciclovir Sales and Growth Rate (2021-2032) & (W Units) Figure 38. Asia Pacific Famciclovir Sales and Growth Rate (2021-2032) & (W Units) Figure 39. Asia Pacific Famciclovir Sales Market Share by Country (2021-2032) Figure 40. China Famciclovir Sales and Growth Rate (2021-2032) & (W Units) Figure 41. Japan Famciclovir Sales and Growth Rate (2021-2032) & (W Units) Figure 42. South Korea Famciclovir Sales and Growth Rate (2021-2032) & (W Units) Figure 43. Southeast Asia Famciclovir Sales and Growth Rate (2021-2032) & (W Units) Figure 44. India Famciclovir Sales and Growth Rate (2021-2032) & (W Units) Figure 45. Australia Famciclovir Sales and Growth Rate (2021-2032) & (W Units) Figure 46. South America, Middle East and Africa Famciclovir Sales and Growth Rate (2021-2032) & (W Units) Figure 47. South America, Middle East and Africa Famciclovir Sales Market Share by Country (2021-2032) Figure 48. Brazil Famciclovir Sales and Growth Rate (2021-2032) & (W Units) Figure 49. South Africa Famciclovir Sales and Growth Rate (2021-2032) & (W Units) Figure 50. Saudi Arabia Famciclovir Sales and Growth Rate (2021-2032) & (W Units) Figure 51. Turkey Famciclovir Sales and Growth Rate (2021-2032) & (W Units) Figure 52. Argentina Famciclovir Sales and Growth Rate (2021-2032) & (W Units) Figure 53. UAE Famciclovir Sales and Growth Rate (2021-2032) & (W Units) Figure 54. Egypt Famciclovir Sales and Growth Rate (2021-2032) & (W Units) Figure 55. Chile Famciclovir Sales and Growth Rate (2021-2032) & (W Units) Figure 56. Global Famciclovir Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Famciclovir Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Famciclovir Revenue (2021-2032) & (US$ Million) Figure 59. North America Famciclovir Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Famciclovir Revenue (2021-2032) & (US$ Million) Figure 61. Europe Famciclovir Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Famciclovir Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Famciclovir Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Famciclovir Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Famciclovir Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Famciclovir Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Famciclovir Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 125 mg Tablets
  • 250 mg Tablets
  • 500 mg Tablets
Applications
  • Cold Sores
  • Shingles
  • Genital Herpes
Companies covered
  • Teva
  • Shandong Luoxin Pharmaceutical Group
  • Novartis
  • Mylan
  • Hainan choitec Pharmaceuticals
  • Chengdu Diao Pharmaceutical Group
  • Beijing Jialin Pharmaceutical
  • Macleods Pharmaceuticals
  • HISUN
  • Hikma
  • HETERO
  • Cipla
  • Aurobindo Pharma
  • Apotex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Famciclovir Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Famciclovir Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Famciclovir Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Famciclovir Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Famciclovir Market Dynamics
  1. 2.1 Famciclovir Industry Trends
  2. 2.2 Famciclovir Industry Drivers
  3. 2.3 Famciclovir Industry Opportunities and Challenges
  4. 2.4 Famciclovir Industry Restraints
3 Famciclovir Market by Manufacturers
  1. 3.1 Global Famciclovir Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Famciclovir Sales by Manufacturers (2021-2026)
  3. 3.3 Global Famciclovir Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Famciclovir Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Famciclovir Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Famciclovir Manufacturers, Product Type & Application
  7. 3.7 Global Famciclovir Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Famciclovir Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Famciclovir Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Famciclovir Tier 1, Tier 2, and Tier 3
4 Famciclovir Market by Type
  1. 4.1 Famciclovir Type Introduction
  2. 4.1.1 125 mg Tablets
  3. 4.1.2 250 mg Tablets
  4. 4.1.3 500 mg Tablets
  5. 4.2 Global Famciclovir Sales by Type
  6. 4.2.1 Global Famciclovir Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Famciclovir Sales by Type (2021-2032)
  8. 4.2.3 Global Famciclovir Sales Market Share by Type (2021-2032)
  9. 4.3 Global Famciclovir Revenue by Type
  10. 4.3.1 Global Famciclovir Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Famciclovir Revenue by Type (2021-2032)
  12. 4.3.3 Global Famciclovir Revenue Market Share by Type (2021-2032)
5 Famciclovir Market by Application
  1. 5.1 Famciclovir Application Introduction
  2. 5.1.1 Cold Sores
  3. 5.1.2 Shingles
  4. 5.1.3 Genital Herpes
  5. 5.2 Global Famciclovir Sales by Application
  6. 5.2.1 Global Famciclovir Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Famciclovir Sales by Application (2021-2032)
  8. 5.2.3 Global Famciclovir Sales Market Share by Application (2021-2032)
  9. 5.3 Global Famciclovir Revenue by Application
  10. 5.3.1 Global Famciclovir Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Famciclovir Revenue by Application (2021-2032)
  12. 5.3.3 Global Famciclovir Revenue Market Share by Application (2021-2032)
6 Global Famciclovir Sales by Region
  1. 6.1 Global Famciclovir Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Famciclovir Sales by Region (2021-2032)
  3. 6.2.1 Global Famciclovir Sales by Region (2021-2026)
  4. 6.2.2 Global Famciclovir Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Famciclovir Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Famciclovir Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Famciclovir Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Famciclovir Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Famciclovir Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Famciclovir Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Famciclovir Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Famciclovir Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Famciclovir Revenue by Region
  1. 7.1 Global Famciclovir Revenue by Region
  2. 7.1.1 Global Famciclovir Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Famciclovir Revenue by Region (2021-2026)
  4. 7.1.3 Global Famciclovir Revenue by Region (2027-2032)
  5. 7.1.4 Global Famciclovir Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Famciclovir Revenue (2021-2032)
  8. 7.2.2 North America Famciclovir Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Famciclovir Revenue (2021-2032)
  11. 7.3.2 Europe Famciclovir Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Famciclovir Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Famciclovir Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Famciclovir Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Famciclovir Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Famciclovir Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Famciclovir Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Shandong Luoxin Pharmaceutical Group
  8. 8.2.1 Shandong Luoxin Pharmaceutical Group Company Information
  9. 8.2.2 Shandong Luoxin Pharmaceutical Group Business Overview
  10. 8.2.3 Shandong Luoxin Pharmaceutical Group Famciclovir Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Shandong Luoxin Pharmaceutical Group Famciclovir Product Portfolio
  12. 8.2.5 Shandong Luoxin Pharmaceutical Group Recent Developments
  13. 8.3 Novartis
  14. 8.3.1 Novartis Company Information
  15. 8.3.2 Novartis Business Overview
  16. 8.3.3 Novartis Famciclovir Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Novartis Famciclovir Product Portfolio
  18. 8.3.5 Novartis Recent Developments
  19. 8.4 Mylan
  20. 8.4.1 Mylan Company Information
  21. 8.4.2 Mylan Business Overview
  22. 8.4.3 Mylan Famciclovir Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Mylan Famciclovir Product Portfolio
  24. 8.4.5 Mylan Recent Developments
  25. 8.5 Hainan choitec Pharmaceuticals
  26. 8.5.1 Hainan choitec Pharmaceuticals Company Information
  27. 8.5.2 Hainan choitec Pharmaceuticals Business Overview
  28. 8.5.3 Hainan choitec Pharmaceuticals Famciclovir Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Hainan choitec Pharmaceuticals Famciclovir Product Portfolio
  30. 8.5.5 Hainan choitec Pharmaceuticals Recent Developments
  31. 8.6 Chengdu Diao Pharmaceutical Group
  32. 8.6.1 Chengdu Diao Pharmaceutical Group Company Information
  33. 8.6.2 Chengdu Diao Pharmaceutical Group Business Overview
  34. 8.6.3 Chengdu Diao Pharmaceutical Group Famciclovir Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Chengdu Diao Pharmaceutical Group Famciclovir Product Portfolio
  36. 8.6.5 Chengdu Diao Pharmaceutical Group Recent Developments
  37. 8.7 Beijing Jialin Pharmaceutical
  38. 8.7.1 Beijing Jialin Pharmaceutical Company Information
  39. 8.7.2 Beijing Jialin Pharmaceutical Business Overview
  40. 8.7.3 Beijing Jialin Pharmaceutical Famciclovir Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Beijing Jialin Pharmaceutical Famciclovir Product Portfolio
  42. 8.7.5 Beijing Jialin Pharmaceutical Recent Developments
  43. 8.8 Macleods Pharmaceuticals
  44. 8.8.1 Macleods Pharmaceuticals Company Information
  45. 8.8.2 Macleods Pharmaceuticals Business Overview
  46. 8.8.3 Macleods Pharmaceuticals Famciclovir Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Macleods Pharmaceuticals Famciclovir Product Portfolio
  48. 8.8.5 Macleods Pharmaceuticals Recent Developments
  49. 8.9 HISUN
  50. 8.9.1 HISUN Company Information
  51. 8.9.2 HISUN Business Overview
  52. 8.9.3 HISUN Famciclovir Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 HISUN Famciclovir Product Portfolio
  54. 8.9.5 HISUN Recent Developments
  55. 8.10 Hikma
  56. 8.10.1 Hikma Company Information
  57. 8.10.2 Hikma Business Overview
  58. 8.10.3 Hikma Famciclovir Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Hikma Famciclovir Product Portfolio
  60. 8.10.5 Hikma Recent Developments
  61. 8.11 HETERO
  62. 8.11.1 HETERO Company Information
  63. 8.11.2 HETERO Business Overview
  64. 8.11.3 HETERO Famciclovir Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 HETERO Famciclovir Product Portfolio
  66. 8.11.5 HETERO Recent Developments
  67. 8.12 Cipla
  68. 8.12.1 Cipla Company Information
  69. 8.12.2 Cipla Business Overview
  70. 8.12.3 Cipla Famciclovir Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Cipla Famciclovir Product Portfolio
  72. 8.12.5 Cipla Recent Developments
  73. 8.13 Aurobindo Pharma
  74. 8.13.1 Aurobindo Pharma Company Information
  75. 8.13.2 Aurobindo Pharma Business Overview
  76. 8.13.3 Aurobindo Pharma Famciclovir Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Aurobindo Pharma Famciclovir Product Portfolio
  78. 8.13.5 Aurobindo Pharma Recent Developments
  79. 8.14 Apotex
  80. 8.14.1 Apotex Company Information
  81. 8.14.2 Apotex Business Overview
  82. 8.14.3 Apotex Famciclovir Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Apotex Famciclovir Product Portfolio
  84. 8.14.5 Apotex Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Famciclovir Value Chain Analysis
  2. 9.1.1 Famciclovir Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Famciclovir Production Mode & Process
  6. 9.2 Famciclovir Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Famciclovir Distributors
  9. 9.2.3 Famciclovir Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst